These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 33558186)
1. National survey identifying community pharmacist preceptors' experience, knowledge, attitudes, and behaviors influencing intent to recommend cannabidiol products. Nichols MA; Arnett SJ; Fa B; Marchionda RA; Cutting MC; McDonald MR; Miller ML J Am Pharm Assoc (2003); 2021; 61(4S):S91-S104. PubMed ID: 33558186 [TBL] [Abstract][Full Text] [Related]
2. Indiana community pharmacist preceptors' knowledge and perceptions of medication-assisted treatment. Davenport ES; Arnett SJ; Nichols MA; Miller ML J Am Pharm Assoc (2003); 2020; 60(3S):S20-S28.e4. PubMed ID: 32094038 [TBL] [Abstract][Full Text] [Related]
3. Community pharmacists' lack of knowledge and confidence in non-prescription cannabidiol products. Patel S; Doroudgar S; Ip EJ Res Social Adm Pharm; 2021 Jul; 17(7):1356-1360. PubMed ID: 33041209 [TBL] [Abstract][Full Text] [Related]
4. A Continuing Pharmacy Education (CPE) Program Assessing Cannabidiol (CBD) Knowledge and Confidence Among Practicing Pharmacists. Farmer SE; Arnold JA; Hughes PJ; Pan K; Gorman GS J Pharm Pract; 2024 Oct; 37(5):1048-1054. PubMed ID: 37933430 [No Abstract] [Full Text] [Related]
5. Illinois Pharmacists and Over the Counter Cannabidiol Products: A Survey on Knowledge and Educational Needs. Link K; Deshpande M; Ferguson M Innov Pharm; 2020; 11(2):. PubMed ID: 34007603 [TBL] [Abstract][Full Text] [Related]
6. A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis. Bawa Z; Saini B; McCartney D; Bedoya-Pérez M; McLachlan AJ; McGregor IS Int J Clin Pharm; 2023 Apr; 45(2):375-386. PubMed ID: 36446995 [TBL] [Abstract][Full Text] [Related]
7. What predicts medication therapy management completion rates? The role of community pharmacy staff characteristics and beliefs about medication therapy management. Adeoye OA; Lake LM; Lourens SG; Morris RE; Snyder ME J Am Pharm Assoc (2003); 2018; 58(4S):S7-S15.e5. PubMed ID: 29731422 [TBL] [Abstract][Full Text] [Related]
8. Tobacco sales in pharmacies: a survey of attitudes, knowledge and beliefs of pharmacists employed in student experiential and other worksites in Western New York. Smith DM; Hyland AJ; Rivard C; Bednarczyk EM; Brody PM; Marshall JR BMC Res Notes; 2012 Aug; 5():413. PubMed ID: 22867129 [TBL] [Abstract][Full Text] [Related]
9. Differences in Cannabidiol-Related Attitudes and Practice Behaviors Between U.S. Primary Care Physicians Practicing in a Single Health Care System Across States With and Without Marijuana Legalization. Sharma P; Wilfahrt RP; Lackore K; Hammond CJ Cannabis Cannabinoid Res; 2024 Aug; 9(4):1038-1047. PubMed ID: 37220016 [No Abstract] [Full Text] [Related]
10. CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults. Wheeler M; Merten JW; Gordon BT; Hamadi H Subst Use Misuse; 2020; 55(7):1138-1145. PubMed ID: 32093530 [No Abstract] [Full Text] [Related]
11. A survey of Wisconsin pharmacists about cannabinoid products: Are we ready to recommend? Emmerling S; Martin B; Schmitz N J Am Pharm Assoc (2003); 2021; 61(6):e71-e75. PubMed ID: 34456146 [TBL] [Abstract][Full Text] [Related]
12. Examining community-based pharmacist perceptions on the care of transgender patients. Aragon KG; Conklin J; Lenell A; Rhodes LA; Marciniak MW J Am Pharm Assoc (2003); 2019; 59(4S):S62-S66. PubMed ID: 31203014 [TBL] [Abstract][Full Text] [Related]
13. Utah pharmacists' knowledge, attitudes, and barriers regarding human papillomavirus vaccine recommendation. Tolentino V; Unni E; Montuoro J; Bezzant-Ogborn D; Kepka D J Am Pharm Assoc (2003); 2018; 58(4S):S16-S23. PubMed ID: 29739667 [TBL] [Abstract][Full Text] [Related]
14. Pharmacist and pharmacy intern perceptions of adolescent vaccination administration. McCauley LM; Lake LM; Madison NR; Huntsman RE; Baker CM J Am Pharm Assoc (2003); 2020; 60(3S):S7-S12.e1. PubMed ID: 32359813 [TBL] [Abstract][Full Text] [Related]
15. Assessment of hemp oil-based cannabidiol use in a community-based pharmacy setting. Gicewicz E; Gatewood SS; Kaefer TN; Nadpara P; Goode JR J Am Pharm Assoc (2003); 2021; 61(4S):S49-S56. PubMed ID: 33745856 [TBL] [Abstract][Full Text] [Related]
16. Perspectives of athletes and pharmacists on pharmacist-provided sports supplement counseling: An exploratory study. Howard MS; DiDonato KL; Janovick DL; Schroeder MN; Powers MF; Azzi AG; Lengel AJ J Am Pharm Assoc (2003); 2018; 58(4S):S30-S36.e2. PubMed ID: 30006185 [TBL] [Abstract][Full Text] [Related]
17. Expectations and knowledge of cannabidiol therapy for childhood epilepsy - A German caregiver survey. Klotz KA; Schönberger J; Nakamura L; San Antonio-Arce V; Bast T; Wiemer-Kruel A; Schubert-Bast S; Borggraefe I; Syrbe S; Jacobs J Epilepsy Behav; 2020 Oct; 111():107268. PubMed ID: 32645621 [TBL] [Abstract][Full Text] [Related]
18. Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis. Failing CJ; Boehnke KF; Riebschleger M Pediatr Rheumatol Online J; 2021 Dec; 19(1):171. PubMed ID: 34903213 [TBL] [Abstract][Full Text] [Related]
19. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Herbert KE; Urmie JM; Newland BA; Farris KB Res Social Adm Pharm; 2006 Sep; 2(3):299-314. PubMed ID: 17138516 [TBL] [Abstract][Full Text] [Related]
20. Determinants of intentions to monitor antihypertensive medication adherence in Irish community pharmacy: a factorial survey. Dillon P; McDowell R; Smith SM; Gallagher P; Cousins G BMC Fam Pract; 2019 Sep; 20(1):131. PubMed ID: 31519171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]